Starkey Evolv AI vs Yeasound RIC800

The Starkey Evolv AI is a premium behind-the-ear prescription hearing aid released in 2022, currently available at $4,598. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #28 of 36 prescription hearing aids tested. This device shows notable strengths in specific performance areas. Music streaming quality stands out at 3.7/5, scoring 1.06 points above the category average—making it a solid choice for users who prioritize audio entertainment. Speech in noise performance reaches 2.8/5, which is 0.81 points above the category average, though the absolute score reflects mixed real-world performance in challenging listening environments. Speech in quiet is solid at 3.4/5, slightly above average. The Evolv AI does show weaknesses in two key areas. Own voice comfort scores 2.1/5, falling 0.65 points below the category average, which may affect how natural your own speech sounds. Feedback handling, while solid in absolute terms at 3.5/5, runs 1.21 points below the category average of 4.71/5—meaning competitors in this price tier generally offer better feedback suppression. At this premium price point, several alternatives deliver stronger overall performance, including the Phonak Sphere Infinio and Oticon Intent. However, the Evolv AI's Expert's Choice Award recognition in 2023 and 2024 reflects its practical strengths. This hearing aid may suit users who prioritize music streaming quality and improved speech understanding in noise over own-voice comfort, and who value Starkey's feature set including rechargeable batteries and hands-free calling for both iPhone and Android.

The Yeasound RIC800 is a mid-priced OTC hearing aid that earned an A grade with a SoundScore of 4.8/5 in our lab testing, placing it #2 among 65 OTC devices tested. At $659, this behind-the-ear rechargeable device delivers performance that significantly outpaces the category average of 3.71/5. Speech clarity is a standout strength. The RIC800 scores 4.4/5 for speech in quiet—a strong result that sits 1.63 points above the OTC category average. Speech in noise performance is more mixed at 2.4/5, though this still lands 0.93 points above the typical OTC device. Music streaming is where this device truly excels, scoring 4.3/5 and outperforming the category average by a substantial 2.38 points—making it one of the better choices for consumers who frequently stream audio from their phone. Feedback handling is excellent at 5.0/5, meaning users shouldn't encounter whistling issues during normal wear. The tradeoff comes with own-voice comfort, which scores 2.1/5—a mixed result that falls 0.41 points below the category average. Some users may notice their own voice sounds more hollow or boomy than expected. The RIC800 earned a 2025 Expert's Choice Award and supports both iPhone and Android streaming. For consumers seeking strong speech performance and exceptional streaming quality in the OTC space, this device represents a compelling option. Those particularly sensitive to own-voice quality may want to compare alternatives, but overall performance places the RIC800 among the top tier of OTC hearing aids we've tested.